Publication Name	World Journal of Gastroenterology
Manuscript ID	10559
Country	China

Received	2014-04-07 11:25
Peer-Review Started	2014-04-07 11:50
To Make the First Decision	2014-05-20 11:12
Return for Revision	2014-05-20 11:44
Revised	2014-06-08 13:12
Second Decision	2014-06-26 17:13
Accepted by Journal Editor-in-Chief
Accepted by Executive Editor-in-Chief	2014-06-26 17:15
Articles in Press	2014-06-26 17:46
Publication Fee Transferred
Edit the Manuscript by Language Editor	2014-07-19 17:20
Typeset the Manuscript	2014-09-11 15:33
Publish the Manuscript Online	2014-10-01 20:25

ISSN	1007-9327 (print) and 2219-2840 (online)
Open Access
Copyright
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Gastroenterology & Hepatology
Manuscript Type	Clinical Trials Study
Article Title	Negative methylation status of Vimentin predicts improved prognosis in pancreatic carcinoma
Manuscript Source	Unsolicited Manuscript
All Author List	Yi-Feng Zhou, Wei Xu, Xia Wang, Jin-Shan Sun, Jing-Jing Xiang, Zhao-Shen Li and Xiao-Feng Zhang
Funding Agency and Grant Number	Funding Agency Grant Number National Natural Science Foundation of China 81001078
Corresponding Author	Dr. Xiao-Feng Zhang, Department of Digestive Medicine, The First People’s Hospital of Hangzhou, Huansha Road 261, Hangzhou 310006, Zhejiang Province, China. zxf837@tom.com
Key Words	Vimentin; Methylation; Pancreatic carcinoma; Prognosis
Core Tip	Vimentin is reported to be an important mesenchymal marker, and plays an important role in epithelial-mesenchymal transition in malignant tumors with regard to cellular adhesion, migration and signaling. In our study, we found that pathological T staging (P < 0.001), adjuvant chemotherapy (P = 0.003) and the Vimentin gene methylation state (P = 0.037) were independent prognostic factors. However, additional experiments and clinical trials are needed to accurately validate this observation.
Publish Date	2014-10-01 20:25
Citation	Zhou YF, Xu W, Wang X, Sun JS, Xiang JJ, Li ZS, Zhang XF. Negative methylation status of Vimentin predicts improved prognosis in pancreatic carcinoma. World J Gastroenterol 2014; 20(36): 13172-13177
URL	http://www.wjgnet.com/1007-9327/full/v20/i36/13172.htm
DOI	http://dx.doi.org/10.3748/wjg.v20.i36.13172

Full Article (PDF)	WJG-20-13172.pdf
Full Article (Word)	WJG-20-13172.doc
Manuscript File	10559-Review.doc
Answering Reviewers	10559-Answering reviewers.pdf
Copyright License Agreement	10559-Copyright assignment.pdf
Non-Native Speakers of English Editing Certificate	10559-Language certificate.pdf
Peer-review Report	10559-Peer review.pdf
Scientific Misconduct Check	10559-CorssCheck.jpg
Scientific Editor Work List	10559-Scientific editor work list.pdf